New York State Common Retirement Fund Clearside Biomedical, Inc. Call Options Transaction History
New York State Common Retirement Fund
- $68.1 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding CLSD
# of Institutions
50Shares Held
11MCall Options Held
5.9KPut Options Held
86.6K-
Vanguard Group Inc Valley Forge, PA2.81MShares$2.25 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$1.76 Million3.43% of portfolio
-
Carmignac Gestion Paris, I01.51MShares$1.21 Million0.02% of portfolio
-
Black Rock Inc. New York, NY798KShares$638,5090.0% of portfolio
-
Geode Capital Management, LLC Boston, MA792KShares$633,7970.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $48.2M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...